Literature DB >> 7442614

Simple and rapid separation of ortho- and paramyxovirus glycoproteins.

F X Bosch, A Mayer, R T Huang.   

Abstract

The hemagglutinin (HA) and neuraminidase (NA) of influenza viruses, as well as the fusion protein (F) and hemagglutinin-neuraminidase (HN) of paramyxoviruses, have been separated in native form using a two-step procedure. The glycoproteins are efficiently extracted from virions using the on-ionic detergent octyl-beta-D-glucoside and are then applied to a column of agarose beads coupled with tyrosine-sulfanilic acid. Pure HA and F are obtained in good yield in the flow-through from this column. NA and HN bind strongly and can be eluted, albeit somewhat contaminated with HA or F, by raising the pH of the column buffer. The separated non-denatured fractions can be used for structural, functional, and antigenic studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7442614     DOI: 10.1007/bf02121808

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  27 in total

1.  Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution.

Authors:  M C Hsu; A Scheid; P W Choppin
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

2.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

3.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

4.  Adsorption of influenza virus to charged groups on natural and artificial surfaces.

Authors:  R T Huang
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

5.  The size and shape of influenza virus neuraminidase.

Authors:  N G Wrigley; J J Skehel; P A Charlwood; C M Brand
Journal:  Virology       Date:  1973-02       Impact factor: 3.616

6.  A new method for purification of myxoviruses by zonal centrifugation with two different sucrose density gradients.

Authors:  H W Chucholowius; R Rott
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

7.  Undisturbed release of influenza virus in the presence of univalent antineuraminidase antibodies.

Authors:  H Brecht; U Hämmerling; R Rott
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

8.  [Studies on the microstructure of infectious particles of the Newcastle disease and on concomitant noninfectious virus-specific particles. Contribution to the classification Myxovirus].

Authors:  R Rott
Journal:  Zentralbl Veterinarmed B       Date:  1965-02

9.  Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus.

Authors:  R T Huang; K Wahn; H D Klenk; R Rott
Journal:  Virology       Date:  1980-07-30       Impact factor: 3.616

10.  Nature of the Sendai virus receptor: glycoprotein versus ganglioside.

Authors:  P S Wu; R W Ledeen; S Udem; Y A Isaacson
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

View more
  3 in total

1.  Evidence for the contribution of the host species to the extent of antigenic variation of N1 influenza virus neuraminidase.

Authors:  F Maywald; F X Bosch; M Orlich; R Rott
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

2.  Monoclonal antibodies to influenza A virus FM1 (H1N1) proteins require individual conditions for optimal reactivity in binding assays.

Authors:  K Kammer
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

3.  Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical procedures.

Authors:  M Gallagher; D J Bucher; R Dourmashkin; J F Davis; G Rosenn; E D Kilbourne
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.